In ovo delivery of Toll-like receptor 2 ligand, lipoteichoic acid induces pro-inflammatory mediators reducing post-hatch infectious laryngotracheitis virus infection - PubMed (original) (raw)
. 2015 Apr 15;164(3-4):170-8.
doi: 10.1016/j.vetimm.2015.02.006. Epub 2015 Feb 20.
Affiliations
- PMID: 25764942
- DOI: 10.1016/j.vetimm.2015.02.006
In ovo delivery of Toll-like receptor 2 ligand, lipoteichoic acid induces pro-inflammatory mediators reducing post-hatch infectious laryngotracheitis virus infection
S Thapa et al. Vet Immunol Immunopathol. 2015.
Abstract
Toll-like receptor (TLR) ligands are pathogen associated molecular patterns (PAMPs) recognized by the TLRs resulting in induction of host innate immune responses. One of the PAMPs that binds to TLR2 and cluster of differentiation (CD) 14 is lipotechoic acid (LTA), which activates downstream signals culminating in the release of pro-inflammatory cytokines. In this study, we investigated whether in ovo LTA delivery leads to the induction of antiviral responses against post-hatch infectious laryngotracheitis virus (ILTV) infection. We first delivered the LTA into embryo day (ED)18 eggs via in ovo route so that the compound is available at the respiratory mucosa. Then the LTA treated and control ED18 eggs were allowed to hatch and the hatched chicken was infected with ILTV intratracheally on the day of hatch. We found that in ovo delivered LTA reduces ILTV infection post-hatch. We also found that in ovo delivery of LTA significantly increases mRNA expression of pro-inflammatory mediators in pre-hatch embryo lungs as well as mononuclear cell infiltration, predominantly macrophages, in lung of post-hatch chickens. Altogether, the data suggest that in ovo delivered LTA could be used to reduce ILTV infection in newly hatched chickens.
Keywords: In ovo; Infectious laryngotracheitis virus; Lipoteichoic acid; Lung; Toll-like receptor 2.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
- Toll-like receptor 2 ligand, lipoteichoic acid is inhibitory against infectious laryngotracheitis virus infection in vitro and in vivo.
Haddadi S, Thapa S, Kameka AM, Hui J, Czub M, Nagy E, Muench G, Abdul-Careem MF. Haddadi S, et al. Dev Comp Immunol. 2015 Jan;48(1):22-32. doi: 10.1016/j.dci.2014.08.011. Epub 2014 Sep 6. Dev Comp Immunol. 2015. PMID: 25195716 - In ovo CpG DNA delivery increases innate and adaptive immune cells in respiratory, gastrointestinal and immune systems post-hatch correlating with lower infectious laryngotracheitis virus infection.
Abdul-Cader MS, Amarasinghe A, Palomino-Tapia V, Ahmed-Hassan H, Bakhtawar K, Nagy E, Sharif S, Gomis S, Abdul-Careem MF. Abdul-Cader MS, et al. PLoS One. 2018 Mar 7;13(3):e0193964. doi: 10.1371/journal.pone.0193964. eCollection 2018. PLoS One. 2018. PMID: 29513732 Free PMC article. - In ovo delivery of CpG DNA reduces avian infectious laryngotracheitis virus induced mortality and morbidity.
Thapa S, Cader MS, Murugananthan K, Nagy E, Sharif S, Czub M, Abdul-Careem MF. Thapa S, et al. Viruses. 2015 Apr 8;7(4):1832-52. doi: 10.3390/v7041832. Viruses. 2015. PMID: 25856635 Free PMC article. - Immune responses to infectious laryngotracheitis virus.
Coppo MJ, Hartley CA, Devlin JM. Coppo MJ, et al. Dev Comp Immunol. 2013 Nov;41(3):454-62. doi: 10.1016/j.dci.2013.03.022. Epub 2013 Apr 6. Dev Comp Immunol. 2013. PMID: 23567343 Review. - Lipoteichoic acids as a major virulence factor causing inflammatory responses via Toll-like receptor 2.
Kang SS, Sim JR, Yun CH, Han SH. Kang SS, et al. Arch Pharm Res. 2016 Nov;39(11):1519-1529. doi: 10.1007/s12272-016-0804-y. Epub 2016 Aug 8. Arch Pharm Res. 2016. PMID: 27498542 Review.
Cited by
- Analysis of Whole-Genome Sequences of Infectious laryngotracheitis Virus Isolates from Poultry Flocks in Canada: Evidence of Recombination.
Perez Contreras A, van der Meer F, Checkley S, Joseph T, King R, Ravi M, Peters D, Fonseca K, Gagnon CA, Provost C, Ojkic D, Abdul-Careem MF. Perez Contreras A, et al. Viruses. 2020 Nov 12;12(11):1302. doi: 10.3390/v12111302. Viruses. 2020. PMID: 33198373 Free PMC article. - Rutin Prevents LTA Induced Oxidative Changes in H9c2 Cells.
Gutiérrez-Venegas G, Fernández-Rojas B, Rosas-Martínez M, Sánchez-Carballido MA. Gutiérrez-Venegas G, et al. Prev Nutr Food Sci. 2020 Jun 30;25(2):203-211. doi: 10.3746/pnf.2020.25.2.203. Prev Nutr Food Sci. 2020. PMID: 32676472 Free PMC article. - Evaluation of Recombinant Herpesvirus of Turkey Laryngotracheitis (rHVT-LT) Vaccine against Genotype VI Canadian Wild-Type Infectious Laryngotracheitis Virus (ILTV) Infection.
Barboza-Solis C, Najimudeen SM, Perez-Contreras A, Ali A, Joseph T, King R, Ravi M, Peters D, Fonseca K, Gagnon CA, van der Meer F, Abdul-Careem MF. Barboza-Solis C, et al. Vaccines (Basel). 2021 Dec 3;9(12):1425. doi: 10.3390/vaccines9121425. Vaccines (Basel). 2021. PMID: 34960175 Free PMC article. - Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses.
Abdul-Cader MS, Amarasinghe A, Abdul-Careem MF. Abdul-Cader MS, et al. Arch Virol. 2016 Aug;161(8):2075-86. doi: 10.1007/s00705-016-2904-x. Epub 2016 May 27. Arch Virol. 2016. PMID: 27233799 Free PMC article. Review. - Host Responses Following Infection with Canadian-Origin Wildtype and Vaccine Revertant Infectious Laryngotracheitis Virus.
Elshafiee EA, Isham IM, Najimudeen SM, Perez-Contreras A, Barboza-Solis C, Ravi M, Abdul-Careem MF. Elshafiee EA, et al. Vaccines (Basel). 2022 May 16;10(5):782. doi: 10.3390/vaccines10050782. Vaccines (Basel). 2022. PMID: 35632538 Free PMC article.